Florence Anthony A. Jr. - Net Worth and Insider Trading

Florence Anthony A. Jr. Net Worth

The estimated net worth of Florence Anthony A. Jr. is at least $1.3 Billion dollars as of 2024-04-25. Florence Anthony A. Jr. is the Director of Robinhood Markets Inc and owns about 23,822,908 shares of Robinhood Markets Inc (HOOD) stock worth over $407 Million. Florence Anthony A. Jr. is the 10% Owner of Arcellx Inc and owns about 4,745,262 shares of Arcellx Inc (ACLX) stock worth over $243 Million. Florence Anthony A. Jr. is also the 10% Owner of Adaptimmune Therapeutics PLC and owns about 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $109 Million. Besides these, Florence Anthony A. Jr. also holds Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Casper Sleep Inc (CSPR) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Cvent Inc (CVT) , Appian Corp (APPN) . Details can be seen in Florence Anthony A. Jr.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Florence Anthony A. Jr. has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).

Transaction Summary of Florence Anthony A. Jr.

To

Florence Anthony A. Jr. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Florence Anthony A. Jr. owns 55 companies in total, including Eargo Inc () , Metacrine Inc () , and Mersana Therapeutics Inc () among others .

Click here to see the complete history of Florence Anthony A. Jr.’s form 4 insider trades.

Insider Ownership Summary of Florence Anthony A. Jr.

Ticker Comapny Transaction Date Type of Owner
Eargo Inc 2020-10-20 10 percent owner
Metacrine Inc 2021-12-22 10 percent owner
Mersana Therapeutics Inc 2020-04-13 10 percent owner
Inozyme Pharma Inc 2020-07-28 10 percent owner
Genocea Biosciences Inc 2022-05-25 10 percent owner
Annexon Inc 2020-07-23 10 percent owner
Nkarta Inc 2020-07-09 10 percent owner
Akouos Inc 2020-06-30 10 percent owner
AVEO Pharmaceuticals Inc 2020-06-19 10 percent owner
Surface Oncology Inc 2018-04-23 10 percent owner
Trevi Therapeutics Inc 2022-04-11 10 percent owner
Imara Inc 2020-03-11 10 percent owner
Champions Oncology Inc 2015-03-11 10 percent owner
Casper Sleep Inc 2020-02-10 director & 10 percent owner
Black Diamond Therapeutics Inc 2020-01-29 10 percent owner
Adaptimmune Therapeutics PLC 2020-01-24 10 percent owner
Regulus Therapeutics Inc 2020-12-04 10 percent owner
Ardelyx Inc 2016-07-18 10 percent owner
Galera Therapeutics Inc 2019-11-06 10 percent owner
Oyster Point Pharma Inc 2019-10-30 10 percent owner
Mirum Pharmaceuticals Inc 2019-07-22 10 percent owner
Nightstar Therapeutics PLC 2019-06-07 10 percent owner
Millendo Therapeutics Inc 2018-12-07 10 percent owner
Marker Therapeutics Inc 2021-03-16 10 percent owner
MuleSoft Inc 2018-05-01 10 percent owner
TRACON Pharmaceuticals Inc 2018-03-27 10 percent owner
Cascadian Therapeutics Inc 2018-03-09 10 percent owner
ARCA biopharma Inc 2018-02-26 10 percent owner
Appian Corp 2017-11-27 10 percent owner
Synlogic Inc 2015-09-30 10 percent owner
Strongbridge Biopharma PLC 2018-01-01 10 percent owner
X4 Pharmaceuticals Inc 2017-11-20 10 percent owner
Achaogen Inc 2016-12-19 10 percent owner
Interleukin Genetics Inc 2016-07-29 10 percent owner
Avalo Therapeutics Inc 2015-10-14 10 percent owner
Cvent Inc 2015-06-11 director
Loxo Oncology Inc 2014-08-06 10 percent owner
Care.com Inc 2014-01-23 director
Savara Inc 2023-07-17 10 percent owner
Tempest Therapeutics Inc 2018-12-07 10 percent owner
Reneo Pharmaceuticals Inc 2021-04-08 10 percent owner
Verona Pharma PLC 2021-01-01 10 percent owner
NeueHealth Inc 2021-06-24 10 percent owner
Desktop Metal Inc 2020-12-09 10 percent owner
Robinhood Markets Inc 2022-05-03 director & 10 percent owner
Arcellx Inc 2022-12-21 10 percent owner
Berkshire Grey Inc 2021-07-21 10 percent owner
IonQ Inc 2021-09-30 10 percent owner
Monte Rosa Therapeutics Inc 2021-06-23 10 percent owner
Senti Biosciences Inc 2022-06-08 10 percent owner
ZeroFox Holdings Inc 2022-08-03 10 percent owner
Enliven Therapeutics Inc 2020-03-11 10 percent owner
Genocea Biosciences Inc 2018-01-19 10 percent owner
Revolution Acceleration Acquisition Corp 2021-07-21 10 percent owner
Korro Bio Inc 2023-11-03 10 percent owner

Florence Anthony A. Jr. Latest Holdings Summary

Florence Anthony A. Jr. currently owns a total of 25 stocks. Among these stocks, Florence Anthony A. Jr. owns 23,822,908 shares of Robinhood Markets Inc (HOOD) as of May 3, 2022, with a value of $407 Million and a weighting of 31.39%. Florence Anthony A. Jr. owns 4,745,262 shares of Arcellx Inc (ACLX) as of December 21, 2022, with a value of $243 Million and a weighting of 18.78%. Florence Anthony A. Jr. also owns 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 24, 2020, with a value of $109 Million and a weighting of 8.38%. The other 22 stocks Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Casper Sleep Inc (CSPR) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Cvent Inc (CVT) , Appian Corp (APPN) have a combined weighting of 41.44% among all his current holdings.

Latest Holdings of Florence Anthony A. Jr.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOOD Robinhood Markets Inc 2022-05-03 23,822,908 17.08 406,895,269
ACLX Arcellx Inc 2022-12-21 4,745,262 51.31 243,455,667
ADAP Adaptimmune Therapeutics PLC 2020-01-24 102,478,668 1.06 108,627,388
SVRA Savara Inc 2023-07-17 24,471,264 4.38 107,061,780
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 24.00 100,469,832
KRRO Korro Bio Inc 2024-04-22 1,090,793 59.48 64,874,914
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
CSPR Casper Sleep Inc 2020-02-10 6,222,412 6.78 42,187,953
ARDX Ardelyx Inc 2016-07-18 5,331,039 6.28 33,478,925
TRVI Trevi Therapeutics Inc 2022-04-11 11,370,376 2.47 28,084,829
MRSN Mersana Therapeutics Inc 2020-04-13 7,961,655 2.90 23,088,800
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 4.28 10,433,309
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 4.46 4,778,573
SURF Surface Oncology Inc 2018-04-23 3,312,877 1.07 3,544,778
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 2.27 1,464,391
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
ILIU Interleukin Genetics Inc 2016-07-29 55,418,811 0.00 249,385
AKAOQ Achaogen Inc 2016-12-19 5,215,128 0.03 130,378
TCON TRACON Pharmaceuticals Inc 2018-03-27 17,330 1.87 32,407
MTCR Metacrine Inc 2021-12-22 2,563,257 0.00 3,589
ABIO ARCA biopharma Inc 2018-02-26 0 3.48 0
GNCAQ Genocea Biosciences Inc 2022-05-25 0 0.00 0
CVT Cvent Inc 2015-06-11 0 6.37 0
APPN Appian Corp 2017-11-27 0 35.69 0

Holding Weightings of Florence Anthony A. Jr.


Florence Anthony A. Jr. Form 4 Trading Tracker

According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 2 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Robinhood Markets Inc is the sale of 1,952 shares on May 3, 2022, which brought Florence Anthony A. Jr. around $19,637.

According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcellx Inc is the sale of 179 shares on December 21, 2022, which brought Florence Anthony A. Jr. around $5,502.

According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 7,500,000 shares on January 24, 2020, which cost Florence Anthony A. Jr. around $5 Million.

More details on Florence Anthony A. Jr.'s insider transactions can be found in the Insider Trading History of Florence Anthony A. Jr. table.

Insider Trading History of Florence Anthony A. Jr.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Florence Anthony A. Jr. Trading Performance

GuruFocus tracks the stock performance after each of Florence Anthony A. Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Florence Anthony A. Jr. is 3.93%. GuruFocus also compares Florence Anthony A. Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Florence Anthony A. Jr. within 3 months outperforms 23 times out of 44 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Florence Anthony A. Jr.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Florence Anthony A. Jr.

Average Return

-30.96%

Average return per transaction

Outperforming Transactions

16%

7 out of 43 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.94 3.93 2.24 -30.96 -41.88 -34.99
Relative Return to S&P 500(%) 5.33 1.09 -4.92 -45.35 -52.5 -48.7

Florence Anthony A. Jr. Ownership Network

Ownership Network List of Florence Anthony A. Jr.

No Data

Ownership Network Relation of Florence Anthony A. Jr.


Florence Anthony A. Jr. Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Florence Anthony A. Jr. is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc () Insider Trades Summary

Over the past 18 months, Florence Anthony A. Jr. made no insider transaction in Eargo Inc (). Other recent insider transactions involving Eargo Inc () include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Florence Anthony A. Jr. Mailing Address

Above is the net worth, insider trading, and ownership report for Florence Anthony A. Jr.. You might contact Florence Anthony A. Jr. via mailing address: 5425 Wisconsin Avenue, Suite 800, Chevy Chase Md 20815.

Discussions on Florence Anthony A. Jr.

No discussions yet.